Search Login Register
Digoxin
(Digitek)
Summary
Description:
A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)
Also Known As:
Digitek; Lanoxicaps; Lanoxin; AWD.pharma Brand of Digoxin; Bertek Brand of Digoxin Show All >>
Networked: 3217
relevant articles (246 outcomes,
442 trials/studies)
for this Drug
Key Diseases for which Digoxin is
Relevant
-
Heart Failure
:
100 outcomes 191 studies in 1045 results
-
Atrial Fibrillation
:
46 outcomes 64 studies in 451 results
-
Poisoning
:
10 outcomes 11 studies in 137 results
-
Supraventricular Tachycardia
:
10 outcomes 8 studies in 87 results
-
Cardiac Arrhythmias (Arrythmia)
:
9 outcomes 10 studies in 141 results
Show All >>
Drugs Related to Digoxin
-
Diuretics
-
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
-
Amiodarone (Amiodarona)
-
Diltiazem (Cardizem)
-
Creatinine
-
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
-
Calcium
-
Captopril (Capoten)
-
Immunoglobulin Fab Fragments
-
Immunoglobulin Fragments
Show All >>
Therapies Related to Digoxin
-
Drug Therapy (Chemotherapy)
-
Electric Countershock (Cardioversion)
-
Hemoperfusion
-
Peritoneal Dialysis
-
Chelation Therapy (Therapy, Chelation)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.